Class summary at a glance.

Every drug in the Macrolide Antimicrobial class tracked across NADAC, Part D Formulary, Part D Spending, FDA Orange Book, and shortage data. Ranked below by CY24 Part D spend. Click any molecule for the full drug profile.

Molecules in class: 1tracked in Part D
CY24 Part D spend: $7.9Mcombined across class
Total Rx claims: 280K240K unique beneficiaries
Generic mfrs (active): 10across all molecules

Every drug in this class, ranked by Part D spend.

CY2024 dataCMS Part D Spending Dashboard

Clarithromycin

280K Part D claims (CY24) · 240K beneficiaries · First FDA approval: 2005-08-25

10 generic mfrs 0 plans require PA

Low NADAC$0.393

→

Avg plan cost$0.847

Part D spend $7.9M 2× spread, current vs floor

Class share

100%

of class CY24 spend

View profile →

Class summary at a glance.

Every drug in this class, ranked by Part D spend.

Related questions.